The Calliditas share price reaction suggests that the Kidney International publication feedback should result in increased uncertainty. The results are mostly in line with should be expected and a negative reaction is mainly justified if some investors has inflated expectations. The current Calliditas valuation suggests that this is a small minority of investors.
LÄS MER